Kainos Group plc Director/PDMR Shareholding (2339X)
August 08 2018 - 9:21AM
UK Regulatory
TIDMKNOS
RNS Number : 2339X
Kainos Group plc
08 August 2018
08 August 2018
Kainos Group plc
("Kainos" or the "Company)
Director and PCA Dealing
The Company was notified on 08 August 2018 that Richard McCann,
Director, has:
1. exercised his 2015 PSP options over 68,345 ordinary shares of
GBP0.005 in the Company ("Ordinary Shares"), at an exercise price
of GBP0.005 per Ordinary Share; and
2. exercised his 2015 SAYE options over 3,237 Ordinary Shares at
an exercise price of GBP1.112 per Ordinary Share; and
3. received a nil value transfer of 100,000 Ordinary Shares from
his spouse/Person Closely Associated ("PCA").
Following this notification, having retained the PSP and SAYE
Ordinary Shares on exercise, Richard McCann and his PCA have a
reportable shareholding of 6,211,582 Ordinary Shares in the issued
share capital of the Company, constituting 5.19% of the issued
share capital of the Company.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Richard McCann
------------------------------ --------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------
a. Position/status COO/CFO & PDMR
------------------------------ --------------------------------------------
b. Initial notification Initial notification
/Amendment
------------------------------ --------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
a. Name Kainos Group plc
------------------------------ --------------------------------------------
b. LEI 213800H2PQMIF3OVZY47
------------------------------ --------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
a. Description of Ordinary Shares of GBP0.005 each
the
Financial instrument/
type of instrument ISIN: GB00BZ0D6727
Identification
code
------------------------------ --------------------------------------------
b. Nature of the transaction Exercise of Options and Retention of Shares
Transfer of Shares from Spouse
------------------------------ --------------------------------------------
c. Price(s) and volume(s) EXERCISE OF2015 PSP
Price(s) Volume(s)
----------
GBP0.005 68,345
----------
EXERCISE OF2015 SAYE
Price(s) Volume(s)
-----------
GBP0.005 3,237
-----------
TRANSFER OF SHARES
FROM SPOUSE
Price(s) Volume(s)
----------
NIL 100,000
----------
------------------------------ --------------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ --------------------------------------------
e. Date of the transaction PSP exercise and transfer to spouse - 07
August 2018
SAYE exercise - 08 August 2018
------------------------------ --------------------------------------------
f. Place of the transaction Outside a trading venue
------------------------------ --------------------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Kerry McCann
------------------------------ ---------------------------------
2. Reason for the notification
-----------------------------------------------------------------
a. Position/status PCA of Richard McCann (PDMR)
------------------------------ ---------------------------------
b. Initial notification Initial notification
/Amendment
------------------------------ ---------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------
a. Name Kainos Group plc
------------------------------ ---------------------------------
b. LEI 213800H2PQMIF3OVZY47
------------------------------ ---------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------
a. Description of Ordinary Shares of GBP0.005 each
the
Financial instrument/
type of instrument ISIN: GB00BZ0D6727
Identification
code
------------------------------ ---------------------------------
b. Nature of the transaction Transfer to Spouse
------------------------------ ---------------------------------
c. Price(s) and volume(s) TRANSFER OF SHARES
TO SPOUSE
Price(s) Volume(s)
----------
Nil 100,000
----------
------------------------------ ---------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ ---------------------------------
e. Date of the transaction 07 August 2018
------------------------------ ---------------------------------
f. Place of the transaction Outside a trading venue
------------------------------ ---------------------------------
Classification: Additional Regulated Information
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc 44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and
Digital Platforms.
The Group's Digital Services include full lifecycle development
and support of customised Digital Services for government and
commercial customers. Kainos is also the leading European partner
for Workday Inc. ('Workday') responsible for implementing Workday's
innovative Software-as-a-Service (SaaS) platform for enterprise
and, now, government customers.
The Group's Digital Platforms comprise specialised digital
products in the mobile healthcare and automated testing arenas.
Smart is an automated testing platform for Workday customers;
Evolve Electronic Medical Records ('EMR') is the market leading
product for the digitisation of patient notes in the Acute sector
of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based
integrated care platform for the NHS and international healthcare
providers; and Smart is an automated testing platform for Workday
customers.
Kainos has over 1,150 people across eleven offices in Europe and
the USA, working interchangeably across its Services and Platforms
divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For
further information, please visit www.kainos.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKFDDNBKDCFK
(END) Dow Jones Newswires
August 08, 2018 09:21 ET (13:21 GMT)
Kainos (LSE:KNOS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kainos (LSE:KNOS)
Historical Stock Chart
From Jul 2023 to Jul 2024